Instil Bio Balance Sheet Health
Financial Health criteria checks 5/6
Instil Bio has a total shareholder equity of $195.0M and total debt of $85.6M, which brings its debt-to-equity ratio to 43.9%. Its total assets and total liabilities are $294.3M and $99.3M respectively.
Key information
43.9%
Debt to equity ratio
US$85.62m
Debt
| Interest coverage ratio | n/a |
| Cash | US$148.77m |
| Equity | US$195.02m |
| Total liabilities | US$99.30m |
| Total assets | US$294.32m |
Financial Position Analysis
Short Term Liabilities: TIL's short term assets ($154.9M) exceed its short term liabilities ($10.3M).
Long Term Liabilities: TIL's short term assets ($154.9M) exceed its long term liabilities ($89.0M).
Debt to Equity History and Analysis
Debt Level: TIL has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TIL's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TIL has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TIL has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 6.5% each year.